Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Intestinal Microbiota Transplantation Combined With Radiochemotherapy and Sintilimab in Neoadjuvant Treatment for Locally Advanced Rectal cancer-a Single Arm, Prospective, Single Center Exploratory Study

NCT06931808 is registered in ClinicalTrials.gov with First Affiliated Hospital of Ningbo University as lead sponsor.

NCT NCT06931808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06931808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Intestinal Microbiota Transplantation Combined With Radiochemotherapy and Sintilimab in Neoadjuvant Treatment for Locally Advanced Rectal cancer-a Single Arm, Prospective, Single Center Exploratory Study
Lead sponsor
First Affiliated Hospital of Ningbo University
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
March 1, 2025
Completion date
August 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized advanced rectal adenocarcinoma